BRCA1 and neoplasm: These characteristic patterns of gains and losses of genomic DNA associated with BRCA1 mutant tumours can be used to identify a larger group of sporadic cancers that are molecularly similar but lack BRCA1 mutations, known as BRCA1-like [20–22].